Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance

Fig. 1

Sensitivity of chemotherapeutic agents to CYLD-knockdown OSCC cells. Human OSCC cell line (SAS) cells were transfected with control siRNA (siN) or CYLD-specific siRNA (siCYLD) and then treated with cisplatin (A), 5-FU (B), carboplatin (C), docetaxel (D), and paclitaxel (E). The cell survival rates of SAS cells were assessed 72 h after treatment. Values are means ± S.D. of quadruple samples. **p < 0.01 vs siN group in Tukey–Kramer method

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us